PARK CITY, Utah–(BUSINESS WIRE)–$2.4M contract from the NIH’s Rapid Acceleration of Diagnostics (RADx®) program accelerates development of ultra-low-cost, at-home diagnostic test
Click here to view original post
Related Articles
“In-Region, For Region”: Cytiva Builds Out $1.6B in Global Expansion Projects
Two of Cytiva’s top executives offer updates on the company’s $1.6 billion in expansion projects worldwide, all to meet growing market demand for its services from developers and manufacturers of advanced therapeutics. The post “In-Region, […]
Phoenix PharmaLabs Awarded $8.7 Million Grant from NIDA to Study Compound for Treatment of Cocaine Use Disorder
WOODS CROSS, Utah–(BUSINESS WIRE)–Phoenix PharmaLabs, Inc. (https://phoenixpharmalabs.com), a private company developing potent, non-addictive treatments for pain and addiction, today announced the receipt of an $8.7 million grant from the National Institute on Drug Abuse (NIDA). […]
Ascletis’ swift surge into obesity continues with competitive oral GLP-1 data
Ascletis Pharma’s rapid-fire expansion into obesity drug development has passed another milestone. The Chinese biotech ticked the publication of multiple ascending dose data off its to-do list Wednesday, linking its oral GLP-1 prospect to 6.3% mean […]
